WallStreetZenWallStreetZen

NASDAQ: CRBP
Corbus Pharmaceuticals Holdings Inc Stock Ownership - Who owns Corbus Pharmaceuticals Holdings?

Insider buying vs selling

Have Corbus Pharmaceuticals Holdings Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Yuval CohenChief Executive Officer2022-08-103,800$0.26
$1.00kBuy
Craig Stuart MillianChief Operating Officer2022-08-105,000$0.26
$1.28kBuy
Sean F. MoranChief Financial Officer2022-08-1020,000$0.26
$5.20kBuy
Yuval CohenChief Executive Officer2022-05-1610,500$0.25
$2.63kBuy
Sean F. MoranChief Financial Officer2022-05-1612,000$0.30
$3.60kBuy

1 of 1

CRBP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRBP insiders and whales buy or sell their stock.

CRBP Shareholders

What type of owners hold Corbus Pharmaceuticals Holdings Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc97.07%4,049,102$35.75MInstitution
Sumner Burstein86.17%3,594,571$31.74MInsider
Knoll Capital Management LP65.93%2,750,000$24.28MInsider
Blackrock Inc56.47%2,355,555$20.80MInstitution
Mark Tepper50.59%2,110,400$18.63MInsider
Geode Capital Management LLC23.64%986,072$8.71MInstitution
David P. Hochman19.63%818,700$7.23MInsider
Two Sigma Investments LP13.67%570,168$5.03MInstitution
Ikarian Capital LLC9.52%397,168$3.51MInstitution
State Street Corp9.48%395,513$3.49MInstitution

1 of 3

CRBP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRBP54.40%45.60%Net Buying
ERYP2.39%0.00%
SGTX53.91%19.59%
KALA0.68%99.32%Net SellingNet Selling
MEIP37.14%9.31%Net BuyingNet Buying

Corbus Pharmaceuticals Holdings Stock Ownership FAQ

Who owns Corbus Pharmaceuticals Holdings?

Corbus Pharmaceuticals Holdings (NASDAQ: CRBP) is owned by 284.32% institutional shareholders, 238.29% Corbus Pharmaceuticals Holdings insiders, and 0.00% retail investors. Sumner Burstein is the largest individual Corbus Pharmaceuticals Holdings shareholder, owning 3.59M shares representing 86.17% of the company. Sumner Burstein's Corbus Pharmaceuticals Holdings shares are currently valued at $26.13M.

If you're new to stock investing, here's how to buy Corbus Pharmaceuticals Holdings stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.